|
⚲
|
| Keyboard |
| Atea Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001593899 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001593899] | |
| 10-Q | [0001593899] | |
| 3 | [0001593899] | |
| 4 | [0001593899] | |
| 8-K | [0001593899] | |
| D | [0001593899] | |
| SC 13D | [0001593899] | |
| SC 13G | [0001593899] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kirsch Arthur S | |
| Atea Pharmaceuticals Inc | |
| Adams Jerome M | |
| Berman Howard | |
| Berger Franklin M | |
| Lucidi Bruno | |
| Duncan Barbara Gayle | |
| Polsky Bruce | |
| Murphy Polly A | |
| Corcoran Andrea | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-03-11 | Option exercise | 60,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-03-11 | Option exercise | 60,000 | $1.24 | 74,400 |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-02-03 | Option exercise | 300,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-02-03 | Option exercise | 300,000 | $1.24 | 372,000 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 11,570 | $4.24 | 49,057 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 51,283 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 54,866 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 16,104 | $4.24 | 68,281 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 106,093 | $4.24 | 449,834 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 16,073 | $4.24 | 68,150 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 272,983 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 12,132 | $4.24 | 51,440 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 41,333 | ||
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 41,533 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 9,750 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 173,500 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 8,750 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 119,520 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 33,333 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 11,250 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||